Ake Hedhammar

Title: Ake Hedhammar: Innovator in Canine Health

Introduction

Ake Hedhammar is a notable inventor based in Dandery, Sweden. He has made significant contributions to the field of veterinary medicine, particularly in the identification of genetic conditions in dogs. His work has implications for both animal health and breeding practices.

Latest Patents

Ake Hedhammar holds a patent for the "Identification of canine leukocyte adhesion deficiency in dogs." This invention relates to an isolated nucleic acid molecule encoding the canine leukocyte integrin β-2 subunit, which has a Cys36Ser missense mutation. This mutation is indicative of a carrier of canine leukocyte adhesion deficiency. The patent also describes a method for identifying dogs that are carriers or affected by this condition. This method involves obtaining a biological sample from a dog and testing it for the Cys36Ser missense mutation, which can indicate whether a dog is a carrier or affected by the deficiency.

Career Highlights

Throughout his career, Ake Hedhammar has focused on advancing veterinary genetics. His innovative approach has led to improved diagnostic methods for canine health issues. His work is essential for breeders and veterinarians in identifying and managing genetic disorders in dogs.

Collaborations

Ake has collaborated with notable colleagues in the field, including Leif H Andersson and James Kijas. These collaborations have furthered research and development in veterinary genetics, enhancing the understanding of canine health.

Conclusion

Ake Hedhammar's contributions to veterinary medicine through his patent on canine leukocyte adhesion deficiency highlight the importance of innovation in animal health. His work continues to impact the field positively, ensuring better health outcomes for dogs.